Acceptance For Treatment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Currently, the safety and efficacy of linvoseltamab in adult patients with relapsed or refractory multiple myeloma is being compared to elotuzumab, pomalidomide, and dexamethasone in a phase 3 clinical trial.

Jo panuwatRegeneron pharmaceuticalsRefractory multiple myeloma accepted forAcceptance for treatmentRefractory multipleLearn how well linvoseltamab works comparedAdult participants withRefractory multiple myeloma